Ismail Boodhwani
Family · Dallas, TXNPI 1033685680
Payments from drug & device makers
Across 289 payments — averaging $28.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- Merck$564
- Johnson & Johnson$529
- GSK$516
- Novo Nordisk$312
- plus $2K from 19 others
What the payments were for
- Food & beverage$8,09398%
- Education$1912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 89 | $2,420 |
| Gilead | 72 | $2,217 |
| Merck | 21 | $564 |
| Johnson & Johnson(2 entities) | 26 | $529 |
| GSK | 8 | $516 |
| Novo Nordisk | 12 | $312 |
| Theratechnologies Inc. | 12 | $296 |
| EMD Serono, Inc. | 9 | $251 |
| Antares Pharma, Inc. | 7 | $206 |
| Janssen Products, LP | 2 | $163 |
| Merz North America, Inc. | 1 | $146 |
| AstraZeneca | 4 | $144 |
| Lilly USA, LLC | 5 | $79 |
| AbbVie | 4 | $78 |
| Hologic Sales And Service, LLC | 2 | $56 |
| Amgen | 2 | $51 |
| Amarin Pharma, Inc. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| VBI Vaccine (delaware) Inc. | 1 | $29 |
| Medtronic | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,285 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 32 | $210 |
| Pantoprazole Sodium | 14 | $178 |
| Metformin Hcl | 25 | $165 |
| Amlodipine Besylate | 22 | $136 |
| Levothyroxine Sodium | 12 | $102 |
| Lisinopril | 21 | $77 |
| Alendronate Sodium | 11 | $70 |
| Losartan Potassium | 19 | $54 |
| Meloxicam | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Hayley McKessonDallas$165K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Richard OrnbergDallas$56K
- Ifeoma OkekeDallas$48K
- Natasha SimmonsDallas$38K
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.